Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy and safety of 2 concentrations
of RX-10045 ophthalmic solution, 0.05% and 0.1%, compared to placebo for the treatment of
ocular inflammation and pain in subjects undergoing cataract surgery.